Related Experiment Video
Updated: Jun 17, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Anesthesia, extremely premature infants and full-scale intelligence quotient at 5 years of age
Joanna J Fifen1,2, Mujtaba Siddique3, Arijit Lodha4
1Department of Anesthesiology, Perioperative and Pain Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Insights
Exposure to Food and Drug Administration (FDA) warned anesthetics in premature infants did not significantly impact their full-scale intelligence quotient (FSIQ) scores at age five. Further research is needed to clarify potential long-term effects.
Area of Science:
- Neonatal Neuroscience
- Developmental Pediatrics
- Anesthesiology
Background:
- Premature infants born before 27 weeks gestational age are at risk for neurodevelopmental deficits.
- Anesthetic agents used in early life may influence brain development.
- The FDA has flagged certain anesthetic drugs for potential risks.
Purpose of the Study:
- To investigate the association between exposure to FDA-warned anesthetics and full-scale intelligence quotient (FSIQ) in premature infants.
- To determine if early anesthetic exposure affects cognitive outcomes at 5 years of age.
Main Methods:
- Retrospective cohort study of 387 premature infants (<27 weeks gestational age) born between 2006-2012.
- Exposure to FDA-warned anesthetics (volatile anesthetics, propofol, benzodiazepines, ketamine, chloral hydrate, barbiturates/phenobarbital) was assessed.
- Associations with FSIQ at age 5 were analyzed using univariable and multivariable regression, with missing data imputation.
Main Results:
- FSIQ scores at 5 years were available for 238 (61.5%) infants.
- 110 (46.2%) infants were exposed to FDA-warned anesthetics.
- Neither unadjusted nor adjusted analyses revealed a significant association between FDA-warned anesthetic exposure and FSIQ scores.
Conclusions:
- Early exposure to FDA-warned anesthetics in extremely premature infants is not significantly associated with reduced FSIQ at 5 years of age.
- The study highlights the need for continued investigation into the neurodevelopmental effects of early-life anesthetic exposure.
- No significant impact on FSIQ was observed for specific anesthetic types or dosages.
Background:
To determine the association between exposure to Food and Drug Administration (FDA) warned anesthetics in premature infants and their full-scale intelligence quotient (FSIQ) score at 5 years of age.
Methods:
Premature infants born <27 weeks gestational age (GA) between January 2006 and December 2012 with FDA anesthetic exposure status were included. Exposures included volatile anesthetics, propofol, benzodiazepines, ketamine, chloral hydrate, and barbiturates/phenobarbital. Exposure was treated as a binary variable with infants stratified into those who were or were not exposed to any FDA warned drug. Associations were explored using univariable and multivariable regressions.
Results:
238 (61.5%) of 387 eligible infants had available FSIQ scores. Of these, 110 (46.2%) were exposed to warned anesthetics. Unadjusted and adjusted imputed case associations (95% CI) between FDA warned anesthetics and FSIQ were -5 (-10 to -2, p = 0.014) and -2 (-7 to 3, p = 0.528) points. An unobserved confounder(s) the strength of severe IVH [-9 points (-15 to -3)] would be required to overturn the directional association between FDA exposure and FSIQ in our complete case model.
Conclusion:
Premature infants exposed to anesthetics flagged by the FDA showed no significant reduction in FSIQ at 5 years of age.
Impact:
It is unclear whether early exposure to anesthetics in premature infants born <27 weeks gestation is associated with full-scale intelligence quotient (FSIQ) at 5 years of age. Our retrospective cohort study included 387 premature infants born <27 weeks gestational age. FSIQ scores were available for 238/387 at 5 years of age of which 110 were exposed to Food and Drug Administration (FDA) warned anesthetic drugs. After missing data imputation and adjustment for maternal and neonatal characteristics, no significant associations were found between FDA warned anesthetic exposure and FSIQ. No adjusted volatile anesthetic or opioid dosage effect was associated with FSIQ.
More Related Videos
Related Concept Videos
Stages of General Anesthesia
Binet's Contribution to Measures of Intelligence
Biological Influences on Intelligence
Environmental Influences on Intelligence
Piaget's Stage 1 of Cognitive Development
Exploration...
Intellectual Disability

